SARS-CoV-2 infection among psoriasis patients in Germany: Data from the German registries PsoBest and CoronaBest.

María José Valencia LópezAnna MeinekeBrigitte StephanStephan Jeff RustenbachAnne KisDiamant ThaçiUlrich MrowietzKristian ReichPetra Staubach-RenzRalph von KiedrowskiHenriette BogenaMatthias Augustin

Published in: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG (2024)

In this cohort of patients with psoriasis or PsA undergoing systemic treatment, SARS-CoV-2 infections were common but less frequent than in the general German population. No risk signals for more severe COVID-19 or increased infection rates were observed in the patients. In addition, systemic treatments remained largely unchanged, so that no risks can be attributed to these therapies.

Keyphrases

sars cov
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prostate cancer
peritoneal dialysis
prognostic factors
coronavirus disease
respiratory syndrome coronavirus
machine learning
early onset
electronic health record
deep learning
big data
smoking cessation